Labege, France

Daniel Caput

USPTO Granted Patents = 10 


Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 138(Granted Patents)


Location History:

  • Toulouse, FR (1995 - 1999)
  • Avignonet Lauragais, FR (2009)
  • Avignolet Lauragais, FR (2000 - 2011)
  • Labege, FR (2010 - 2012)

Company Filing History:


Years Active: 1995-2012

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Daniel Caput

Introduction

Daniel Caput is a notable inventor based in Labege, France. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and polypeptides. With a total of 10 patents to his name, Caput's work has had a substantial impact on medical research and therapeutic applications.

Latest Patents

Among his latest patents, one focuses on IL-13 receptor antibodies. This invention relates to monoclonal and polyclonal antibodies capable of specifically recognizing IL-13 receptor α and their uses. Another significant patent involves purified polypeptides having IL-13 receptor activity. This invention pertains to a purified polypeptide comprising an amino acid sequence chosen from the sequence SEQ ID NO:4 or biologically active amino acid sequences derived from SEQ ID NO:4.

Career Highlights

Throughout his career, Daniel Caput has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Caput has collaborated with esteemed colleagues such as Pascual Ferrara and Natalio Vita. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biotechnology.

Conclusion

Daniel Caput's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in medical research and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…